Biosig Technologies (OTC: BSGM) is a development stage medical device company that engages in developing technology platforms for the purposes of reducing noise from cardiac recordings during electrophysiology studies. The company’s main product under development is PURE (Precise Uninterrupted Real-time evaluation of Electrograms) EP system, a surface electrocardiogram and intracardiac multichannel recording and analysis system that acquires, processes and displays electrocardiogram and electrograms required during electrophysiology studies and ablation procedures. For more information, visit the company’s website at www.biosigtech.com